{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T12:23:32Z","timestamp":1789302212910,"version":"build-2803163510"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.taap.2024.117040","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T08:12:43Z","timestamp":1721290363000},"page":"117040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The role of drug efflux and uptake transporters in the plasma pharmacokinetics and tissue disposition of morphine and its main metabolites"],"prefix":"10.1016","volume":"490","author":[{"given":"Margarida L.","family":"F. Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paniz","family":"Heydari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Mart\u00ednez-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malika","family":"el Yattouti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Lebre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos H.","family":"Beijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred H.","family":"Schinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.taap.2024.117040_bb0005","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0024-3205(95)00311-S","article-title":"The apparent affinity of Morphine-3-glucuronide at \u039c1-opioid receptors results from morphine contamination: demonstration using HPLC and radioligand binding","volume":"57","author":"Bartlett","year":"1995","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.taap.2024.117040_bb0010","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1476-5381.1960.tb00277.x","article-title":"The anatomical basis of the Straub phenomenon","volume":"15","author":"Bilbey","year":"1960","journal-title":"Br. J. Pharmacol. Chemother."},{"issue":"6","key":"10.1016\/j.taap.2024.117040_bb0015","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1046\/j.1471-4159.2003.01990.x","article-title":"Evidence for an active transport of morphine-6-\u03b2-D-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier","volume":"86","author":"Bourasset","year":"2003","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.taap.2024.117040_bb0020","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.clpt.6100385","article-title":"Association of ABCB1\/MDR1 and OPRM1 gene polymorphisms with morphine pain relief","volume":"83","author":"Campa","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.taap.2024.117040_bb0025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.pharmthera.2006.04.009","article-title":"Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs","volume":"112","author":"Cascorbi","year":"2006","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.taap.2024.117040_bb0030","doi-asserted-by":"crossref","DOI":"10.2174\/1570159X15666170504095823","article-title":"Opioids and the blood-brain barrier: a dynamic interaction with consequences on drug disposition in brain","volume":"15","author":"Chaves","year":"2017","journal-title":"Curr. Neuropharmacol."},{"issue":"8","key":"10.1016\/j.taap.2024.117040_bb0035","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.2174\/1570159X15666170504095823","article-title":"Opioids and the blood-brain barrier: a dynamic interaction with consequences on drug disposition in brain","volume":"15","author":"Chaves","year":"2017","journal-title":"Curr. Neuropharmacol."},{"issue":"9","key":"10.1016\/j.taap.2024.117040_bb0040","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1200\/JCO.2001.19.9.2542","article-title":"Strategies to manage the adverse effects of Oral morphine: an evidence-based report","volume":"19","author":"Cherny","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2024.117040_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/10915810600746023","article-title":"Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters","author":"Choudhuri","year":"2006","journal-title":"Int. J. Toxicol."},{"issue":"1","key":"10.1016\/j.taap.2024.117040_bb0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1399-6576.1997.tb04625.x","article-title":"Morphine metabolites","volume":"41","author":"Christrup","year":"1997","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"7","key":"10.1016\/j.taap.2024.117040_bb0055","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1023\/A:1010984110732","article-title":"Effect of Mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds","volume":"18","author":"Dagenais","year":"2001","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.taap.2024.117040_bb0060","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2125.2000.00226.x","article-title":"Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine","volume":"50","author":"Drewe","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2024.117040_bb0065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/psp4.12144","article-title":"Characterization of contributing factors to variability in morphine clearance through PBPK modeling implemented with OCT1 transporter","volume":"6","author":"Emoto","year":"2017","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.taap.2024.117040_bb0070","article-title":"Morphine and loperamide interact differently with uptake transporters of the OATP-family (Abstract)","author":"Engel","year":"2014","journal-title":"Jahrestagung der Am. Soc. Anesth."},{"key":"10.1016\/j.taap.2024.117040_bb0075","series-title":"The Essence of Analgesia and Analgesics","first-page":"475","article-title":"Morphine-6-Glucuronide","author":"Eskaros","year":"2010"},{"issue":"2","key":"10.1016\/j.taap.2024.117040_bb0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00280-009-1029-2","article-title":"Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with Cancer","volume":"65","author":"Fujita","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"7","key":"10.1016\/j.taap.2024.117040_bb0085","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00424-014-1596-x","article-title":"Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and Neurosteriods in the CNS","volume":"467","author":"Gao","year":"2015","journal-title":"Pflugers Arch. - Eur. J. Physiol."},{"issue":"8","key":"10.1016\/j.taap.2024.117040_bb0090","first-page":"2477","article-title":"Transporter-mediated disposition of opioids: implications for clinical drug interactions","volume":"32","author":"Gharavi","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.taap.2024.117040_bb0095","first-page":"215","article-title":"Membrane transporters in drug development","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7\u20138","key":"10.1016\/j.taap.2024.117040_bb0100","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/00498250801986951","article-title":"Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family","volume":"38","author":"Hagenbuch","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.taap.2024.117040_bb0105","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.mam.2012.10.009","article-title":"The SLCO (former SLC21) superfamily of transporters","author":"Hagenbuch","year":"2013","journal-title":"Mol. Asp. Med."},{"issue":"3","key":"10.1016\/j.taap.2024.117040_bb0110","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/cpt.1249","article-title":"Influence of OCT1 ontogeny and genetic variation on morphine disposition in critically ill neonates: lessons from PBPK modeling and clinical study","volume":"105","author":"Hahn","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.taap.2024.117040_bb0115","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/cpt.1249","article-title":"Influence of OCT1 ontogeny and genetic variation on morphine disposition in critically ill neonates: lessons from PBPK modeling and clinical study","volume":"105","author":"Hahn","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.taap.2024.117040_bb0120","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0091-3057(02)00925-5","article-title":"Pharmacokinetic differences of morphine and morphine-glucuronides are reflected in locomotor activity","volume":"73","author":"Handal","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"8583","key":"10.1016\/j.taap.2024.117040_bb0125","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(88)91256-1","article-title":"Enterohepatic circulation of morphine","volume":"331","author":"Hanks","year":"1988","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.taap.2024.117040_bb0130","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2165\/00003088-199324040-00007","article-title":"Morphine pharmacokinetics and metabolism in humans","volume":"24","author":"Hasselstr\u00f6m","year":"1993","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.taap.2024.117040_bb0135","article-title":"Development and validation of a UPLC-MS\/MS method with a broad linear dynamic range for the quantification of morphine, morphine-3-glucuronide and morphine-6-glucuronide in mouse plasma and tissue homogenates","author":"Heydari","year":"2020","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.taap.2024.117040_bb0140","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clpt.2005.05.011","article-title":"Transporters and drug therapy: implications for drug disposition and disease","author":"Ho","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.taap.2024.117040_bb0145","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/clpt.2012.143","article-title":"Hepatocyte hopping of OATP1B substrates contributes to efficient hepatic detoxification","volume":"92","author":"Iusuf","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.taap.2024.117040_bb0150","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1634\/stemcells.2005-0150","article-title":"Contribution of the ABC transporters Bcrp1 and Mdr1a\/1b to the side population phenotype in mammary gland and bone marrow of mice","volume":"23","author":"Jonker","year":"2005","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.taap.2024.117040_bb0155","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","author":"Kalliokoski","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.taap.2024.117040_bb0160","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.xphs.2017.04.001","article-title":"The organic anion\u2013transporting peptide 2B1 is localized in the basolateral membrane of the human jejunum and Caco-2 monolayers","volume":"106","author":"Keiser","year":"2017","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.taap.2024.117040_bb0165","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.clpt.2003.08.011","article-title":"Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine","volume":"74","author":"Kharasch","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.taap.2024.117040_bb0170","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/med.20035","article-title":"Morphine-6-glucuronide: actions and mechanisms","volume":"25","author":"Kilpatrick","year":"2005","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.taap.2024.117040_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114534","article-title":"OATP2B1 \u2013 the underrated member of the organic anion transporting polypeptide family of drug transporters?","volume":"188","author":"Kinzi","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2024.117040_bb0180","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/019262338801600205","article-title":"Intestinal and hepatobiliary disposition of drugs","volume":"16","author":"Klaassen","year":"1988","journal-title":"Toxicol. Pathol."},{"issue":"6","key":"10.1016\/j.taap.2024.117040_bb0185","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/bja\/aeu186","article-title":"Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide","volume":"113","author":"Klimas","year":"2014","journal-title":"Br. J. Anaesth."},{"issue":"4","key":"10.1016\/j.taap.2024.117040_bb0190","first-page":"187","article-title":"Species difference of site-selective glucuronidation of morphine","volume":"14","author":"Kuo","year":"1991","journal-title":"Aust. J. Pharm."},{"issue":"2","key":"10.1016\/j.taap.2024.117040_bb0195","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/jpet.117.240382","article-title":"Comprehensive characterization of mouse UDP-glucuronosyltransferase (Ugt) belonging to the Ugt2b subfamily: identification of Ugt2b36 as the predominant isoform involved in morphine glucuronidation","volume":"361","author":"Kurita","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.taap.2024.117040_bb0200","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1023\/A:1011938112599","article-title":"Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat","volume":"15","author":"Letrent","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.taap.2024.117040_bb0205","article-title":"Current trends in drug metabolism and pharmacokinetics","author":"Li","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.taap.2024.117040_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116644","article-title":"Interplay of OATP1A\/1B\/2B1 uptake transporters and ABCB1 and ABCG2 efflux transporters in the handling of bilirubin and drugs","volume":"175","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2024.117040_bb0215","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1152\/physiol.00046.2006","article-title":"Structure and function of ABC transporters","author":"Linton","year":"2007","journal-title":"Physiology"},{"issue":"4","key":"10.1016\/j.taap.2024.117040_bb0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/J354v16n04_02","article-title":"Clinical pharmacokinetics of morphine","volume":"16","author":"Lugo","year":"2002","journal-title":"J. Pain Palliat. Care Pharmacother."},{"issue":"4","key":"10.1016\/j.taap.2024.117040_bb0225","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2133\/dmpk.23.223","article-title":"Impact of genetic polymorphisms of transporters on the pharmacokinetic, Pharmacodynamic and toxicological properties of anionic drugs","volume":"23","author":"Maeda","year":"2008","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.taap.2024.117040_bb0230","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.pharmthera.2018.12.009","article-title":"Organic anion transporting polypeptide 2B1 \u2013 more than a glass-full of drug interactions","volume":"196","author":"McFeely","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"9171","key":"10.1016\/j.taap.2024.117040_bb0235","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/S0140-6736(99)03528-X","article-title":"Opioids in pain management","volume":"353","author":"McQuay","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.taap.2024.117040_bb0240","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1191\/026921699678158579","article-title":"The role of morphine glucuronides in cancer pain","volume":"13","author":"Mercadante","year":"1999","journal-title":"Palliat. Med."},{"key":"10.1016\/j.taap.2024.117040_bb0245","series-title":"Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System Pharmacotherapy","author":"Miller","year":"2008"},{"issue":"7","key":"10.1016\/j.taap.2024.117040_bb0250","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2217\/14622416.8.7.787","article-title":"Role of OATP transporters in the disposition of drugs","volume":"8","author":"Niemi","year":"2007","journal-title":"Pharmacogenomics"},{"issue":"9","key":"10.1016\/j.taap.2024.117040_bb0255","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/jcph.1873","article-title":"Pharmacogenomics and morphine","volume":"61","author":"Ofoegbu","year":"2021","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2024.117040_bb0260","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/cpt197517131","article-title":"Morphine binding to human plasma proteins","volume":"17","author":"Olsen","year":"1975","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2024.117040_bb0265","series-title":"Review of Opioid Pharmacogenetics and Considerations for Pain Management. Pharmacotherapy","first-page":"1105","author":"Owusu Obeng","year":"2017"},{"issue":"11","key":"10.1016\/j.taap.2024.117040_bb0270","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/jps.1131","article-title":"Limited phase I study of Morphine-3-glucuronide","volume":"90","author":"Penson","year":"2001","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.taap.2024.117040_bb0275","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2125.2002.01554.x","article-title":"The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide","volume":"53","author":"Penson","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.taap.2024.117040_bb0280","article-title":"Opioids for cancer pain: the challenge of optimizing treatment","volume":"59","author":"Plante","year":"2010","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.taap.2024.117040_bb0285","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/mp0500871","article-title":"P-glycoprotein recognition of substrates and circumvention through rational drug design","volume":"3","author":"Raub","year":"2006","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.taap.2024.117040_bb0290","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2174\/187152010794473957","article-title":"ABC transporters: Unvalidated therapeutic targets in cancer and the CNS","volume":"10","author":"Robey","year":"2011","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"1","key":"10.1016\/j.taap.2024.117040_bb0295","doi-asserted-by":"crossref","first-page":"10406","DOI":"10.1038\/s41598-017-11120-4","article-title":"Morphine-induced hyperalgesia involves Mu opioid receptors and the metabolite Morphine-3-glucuronide","volume":"7","author":"Roeckel","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.taap.2024.117040_bb0300","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2125.1983.tb02148.x","article-title":"Morphine metabolism in cancer patients on increasing oral doses-no evidence for autoinduction or dose-dependence","volume":"16","author":"Sawe","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2024.117040_bb0305","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-59745-205-2_4","article-title":"Pharmacogenetics of membrane transporters","volume":"vol. 448","author":"Sissung","year":"2008"},{"issue":"7","key":"10.1016\/j.taap.2024.117040_bb0310","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clin. Proc."},{"issue":"3","key":"10.1016\/j.taap.2024.117040_bb0315","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.clpt.6100095","article-title":"Pharmacogenetics of opioids","volume":"81","author":"Somogyi","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2024.117040_bb0320","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejps.2015.03.020","article-title":"A review of morphine and Morphine-6-glucuronide\u2019s pharmacokinetic-pharmacodynamic relationships in experimental and clinical pain","volume":"74","author":"Sverrisd\u00f3ttir","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"issue":"07","key":"10.1016\/j.taap.2024.117040_bb0325","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1017\/S1461145709990848","article-title":"Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)","volume":"13","author":"Tournier","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"26","key":"10.1016\/j.taap.2024.117040_bb0330","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.2174\/138161211797440203","article-title":"Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology","volume":"17","author":"Tournier","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.taap.2024.117040_bb0335","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bcp.2013.06.019","article-title":"Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration","volume":"86","author":"Tzvetkov","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2024.117040_bb0340","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.taap.2024.117040_bb0345","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1124\/dmd.108.024315","article-title":"Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of human organic anion-transporting polypeptide 1B1 (SLCO1B1)","volume":"37","author":"van de Steeg","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"8","key":"10.1016\/j.taap.2024.117040_bb0350","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1172\/JCI42168","article-title":"Organic anion transporting polypeptide 1a\/1b\u2013knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs","volume":"120","author":"van de Steeg","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.taap.2024.117040_bb0355","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/1078-0432.CCR-12-2080","article-title":"Influence of human OATP1B1, OATP1B3, and OATP1A2 on the pharmacokinetics of methotrexate and paclitaxel in humanized transgenic mice","volume":"19","author":"van de Steeg","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.taap.2024.117040_bb0360","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1213\/01.ane.0000217197.96784.c3","article-title":"Morphine-6-glucuronide: Morphine\u2019s successor for postoperative pain relief?","volume":"102","author":"van Dorp","year":"2006","journal-title":"Anesth. Analg."},{"issue":"11","key":"10.1016\/j.taap.2024.117040_bb0365","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/14656566.9.11.1955","article-title":"Morphine-6-glucuronide: potency and safety compared with morphine","volume":"9","author":"van Dorp","year":"2008","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.taap.2024.117040_bb0370","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tips.2005.11.007","article-title":"The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins","author":"Van Herwaarden","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.taap.2024.117040_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008786","article-title":"Physiologically based pharmacokinetic\/Pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and children","volume":"17","author":"Verscheijden","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.taap.2024.117040_bb0380","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.addr.2008.08.007","article-title":"Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice","author":"Vlaming","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.taap.2024.117040_bb0385","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00000542-200204000-00019","article-title":"Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein","volume":"96","author":"Wandel","year":"2002","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.taap.2024.117040_bb0390","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00007691-199506000-00013","article-title":"Plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide after intravenous and oral administration to healthy volunteers","volume":"17","author":"Westerling","year":"1995","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.taap.2024.117040_bb0395","article-title":"Oral morphine for cancer pain","volume":"2016","author":"Wiffen","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.taap.2024.117040_bb0400","first-page":"7","article-title":"Structure and mechanism of ABC transporters","author":"Wilkens","year":"2015","journal-title":"F1000Prime Rep."},{"issue":"3","key":"10.1016\/j.taap.2024.117040_bb0405","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/sj.bjp.0702804","article-title":"The role of P-glycoprotein in blood-brain barrier transport of morphine: transcortical microdialysis studies in Mdr1a (\u2212\/\u2212) and Mdr1a (+\/+) mice","volume":"128","author":"Xie","year":"1999","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2024.117040_bb0410","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/toxsci\/kfy093","article-title":"P-glycoprotein on blood-brain barrier plays a vital role in fentanyl brain exposure and respiratory toxicity in rats","volume":"164","author":"Yu","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"20","key":"10.1016\/j.taap.2024.117040_bb0415","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1073\/pnas.0502530102","article-title":"Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception","volume":"102","author":"Zelcer","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.taap.2024.117040_bb0420","first-page":"11","article-title":"Morphine addiction and oxidative stress: the potential effects of thioredoxin-1","author":"Zeng","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2024.117040_bb0425","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/00498250802017715","article-title":"A regulatory viewpoint on transporter-based drug interactions","author":"Zhang","year":"2008","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1016\/j.taap.2024.117040_bb0430","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in microsoft excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Prog. Biomed."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24002382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24002382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T23:26:16Z","timestamp":1723332376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X24002382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":86,"alternative-id":["S0041008X24002382"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.117040","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of drug efflux and uptake transporters in the plasma pharmacokinetics and tissue disposition of morphine and its main metabolites","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.117040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117040"}}